PER 0.00% 10.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-25

  1. 3,247 Posts.
    lightbulb Created with Sketch. 278
    Well it would be fair to acknowledge that it is quite astonishing to realise the number of non holders that all
    of the sudden came out of their holes when there is the suspect that something,maybe
    positive, is coming on ANP's way. Why not before why now so many vultures feel
    the urge to express their critical negativity?
    I am still very critical and sceptical on Diamond managerial capacity to run the company due
    to poor results in the past 16 years and still think that the company
    would benefit if a change in his position will occur but for once (not sure if and how long it will last)
    the fact that Australian Ethical Investment are prepared to buy in for approx $1mil it give me a hint of
    positivity. Something else should also make us thinking is how come the largest share holders, such as
    Leo, they still accept Diamond in that position ?
    Well as mentioned before I am still here all the way today was better than yesterday but may worse than
    tomorrow. Will see.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.